This site is intended for Healthcare Professionals only

biosimilars

money-2023-1280

‘Spiralling’ drugs tax will force ICBs to find extra £37 million annually

In a report published today, the BGMA said the government's rising tax puts future drug launches in the UK "in jeopardy."

30 Oct 2023

rheumatoid arthritis summary.jpg

Biosimilars on the menu for moderate rheumatoid arthritis

NICE guidance previously recommended biologics only for severe RA.

23 Jul 2021

Change privacy settings